Insights

Clinical deployment Target hospitals andCath labs performing high-volume endovascular procedures where the Early Bird Bleed Monitoring System is already FDA-approved and has field experience, highlighting mid-point enrollment in SAFE-MCS trials to showcase real-world usage and potential ROI.

Expansion potential Leverage the recent leadership appointment of CEO Mike MacKinnon and ongoing SAFE-MCS trial momentum to position Saranas as the standard of care for early bleed detection, pursuing partnerships with large health systems and contract research organizations conducting complex PCI and MCS procedures.

Clinical evidence Emphasize the system’s adoption history (over 1,200 treated patients) and FDA-approved status to build credibility with procurement and clinical champions, while offering pilot programs or expanded-access studies to accelerate adoption in target accounts.

Financing path Highlight the company’s funding footprint and scalable revenue potential to financial stakeholders within target hospitals, presenting total cost of ownership analyses and reimbursement-friendly narratives to aid in budget approval and CAPEX/OPEX alignment.

Strategic partnerships Identify collaboration opportunities with medtech distributors, vascular access device makers, and interoperability-focused platforms (PACS, EHRs) to integrate monitoring data, expand go-to-market reach, and create bundled offerings for endovascular care teams.

Similar companies to Saranas

Saranas Tech Stack

Saranas uses 8 technology products and services including Squarespace, WordPress, Google Cloud, and more. Explore Saranas's tech stack below.

Media & News

Saranas's Email Address Formats

Saranas uses at least 4 email formats:
Saranas Email FormatsExamplePercentage
FLast@saranas.comJDoe@saranas.com
64%
First@saranas.comJohn@saranas.com
15%
First_Last@saranas.comJohn_Doe@saranas.com
12%
LastFi@saranas.comDoeJo@saranas.com
9%

Frequently Asked Questions

What is Saranas's phone number?

Minus sign iconPlus sign icon
You can contact Saranas's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Saranas's official website and social media links?

Minus sign iconPlus sign icon
Saranas's official website is saranas.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Saranas generate?

Minus sign iconPlus sign icon
As of October 2026, Saranas's annual revenue is estimated to be $1M - $10M.

What is Saranas's NAICS code?

Minus sign iconPlus sign icon
Saranas's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Saranas have currently?

Minus sign iconPlus sign icon
As of October 2026, Saranas has approximately 8 employees across 2 continents, including North America and Asia. Key team members include Chief Operating Officer: R. S., Vice President Of Sales: F. N. and Senior Vp; Operations: K. B. Explore Saranas's employee directory with LeadIQ.

What industry does Saranas belong to?

Minus sign iconPlus sign icon
Saranas operates in the Medical Equipment Manufacturing industry.

What technology does Saranas use?

Minus sign iconPlus sign icon
Saranas's tech stack includes Squarespace, WordPress, Google Cloud, jQuery Migrate, HubSpot, WP Engine, PHP and Piwik.

What is Saranas's email format?

Minus sign iconPlus sign icon
Saranas's email format typically follows the pattern of FLast@saranas.com. Find more Saranas email formats with LeadIQ.

How much funding has Saranas raised to date?

Minus sign iconPlus sign icon
As of October 2026, Saranas has raised $29M in funding. The last funding round occurred on Jul 19, 2021 for $13M.

When was Saranas founded?

Minus sign iconPlus sign icon
Saranas was founded in 2013.
Saranas logo

Saranas

Medical Equipment ManufacturingTexas, United States2-10 Employees

Saranas is a small medical device company based in Houston, Texas. It develops technologies to detect and monitor bleeding complications associated with vascular access procedures. Its flagship Early Bird Bleed Monitoring System uses a vascular access sheath with embedded sensors to measure the electrical resistance across a blood vessel, enabling detection of bleeding during endovascular procedures such as transcatheter aortic valve replacement and other complex cardiac interventions. The system serves interventional cardiology teams and other clinicians performing endovascular procedures who require real-time bleed surveillance. It sits within the medical equipment manufacturing sector, focusing on procedural safety in vascular access contexts. Notable recent developments include the 2022 launch of the Early Bird system and the 2023 progress updates on the SAFE-MCS clinical trial.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
2-10

Section iconFunding & Financials

  • $29M

    Saranas has raised a total of $29M of funding over 8 rounds. Their latest funding round was raised on Jul 19, 2021 in the amount of $13M as a Series B.

  • $1M - $10M

    Saranas's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.